Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives

Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives

US Patent 6589750 · Granted Jul 8, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of VHH antibodies for the preparation of peptide vectors for delivering a su2019
Variable domains of camelid heavy-chain antibodies directed against glial fibril2018
Pharmaceutical compositions containing peptides derived from human BPLP protein2017
Methods for treating pain by administering peptides derived from human basic pro2016
VHH antibodies used as peptide vectors for delivering a substance of interest2016
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectop2016
Method for detecting human BPLP protein or a maturation product thereof2014
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectop2014
Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectop2014
Variable domains of camelid heavy-chain antibodies directed against glial fibril2013
Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid r2012
Peptides derived from human BPLP protein2011